218 related articles for article (PubMed ID: 37531886)
1. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of transoral robotic and non-robotic surgeries to treat oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma: A multi-center retrospective observational study in Japan.
Sano D; Shimizu A; Tateya I; Fujiwara K; Mori T; Miyamoto S; Nishikawa D; Terada T; Yasumatsu R; Ueda T; Matsumoto F; Kishimoto Y; Maruo T; Fujimoto Y; Tsukahara K; Yoshimoto S; Nibu KI; Oridate N
Auris Nasus Larynx; 2021 Jun; 48(3):502-510. PubMed ID: 33632582
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
4. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.
Groysman M; Yi SK; Robbins JR; Hsu CC; Julian R; Bauman JE; Baker A; Wang SJ; Bearelly S
Am J Otolaryngol; 2022; 43(1):103243. PubMed ID: 34583290
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract][Full Text] [Related]
6. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
8. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
9. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
10. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma.
Nguyen AT; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Shiao SL; Ho AS; Zumsteg ZS
JAMA Oncol; 2020 Oct; 6(10):1555-1562. PubMed ID: 32816023
[TBL] [Abstract][Full Text] [Related]
12. Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC; Bur AM; Schmitt AC; Jackson R; Steuer CE; Beitler JJ; Patel MR
ORL J Otorhinolaryngol Relat Spec; 2023; 85(2):80-87. PubMed ID: 36538901
[TBL] [Abstract][Full Text] [Related]
13. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma.
Cracchiolo JR; Roman BR; Kutler DI; Kuhel WI; Cohen MA
J Surg Oncol; 2016 Sep; 114(4):405-11. PubMed ID: 27392812
[TBL] [Abstract][Full Text] [Related]
14. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
[TBL] [Abstract][Full Text] [Related]
16. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
17. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
[TBL] [Abstract][Full Text] [Related]
18. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract][Full Text] [Related]
19. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
[TBL] [Abstract][Full Text] [Related]
20. Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.
Persky MJ; Albergotti WG; Rath TJ; Kubik MW; Abberbock S; Geltzeiler M; Kim S; Duvvuri U; Ferris RL
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):660-666. PubMed ID: 29182490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]